Page last updated: 2024-10-29

isocarboxazid and Parkinson Disease

isocarboxazid has been researched along with Parkinson Disease in 3 studies

Isocarboxazid: An MAO inhibitor that is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in the treatment of panic disorder and the phobic disorders. (From AMA, Drug Evaluations Annual, 1994, p311)

Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jones, AB1
Pare, CM1
Nicholson, WJ1
Price, K1
Stacey, RS1
Figuerido, JA1
De la HerrĂ¡n, J1
Dandiya, PC1
Bhargava, LP1

Trials

1 trial available for isocarboxazid and Parkinson Disease

ArticleYear
Brain amine concentrations after monoamine oxidase inhibitor administration.
    British medical journal, 1972, Jan-01, Volume: 1, Issue:5791

    Topics: Aged; Alkynes; Autopsy; Brain; Brain Stem; Caudate Nucleus; Chlorpromazine; Dopamine; Humans; Hypoth

1972

Other Studies

2 other studies available for isocarboxazid and Parkinson Disease

ArticleYear
[Personal experience in the treatment of Parkinson's disease with L-Dopa].
    Revista clinica espanola, 1970, Dec-31, Volume: 119, Issue:6

    Topics: Adult; Aged; Dihydroxyphenylalanine; Drug Synergism; Female; Humans; Isocarboxazid; Male; Middle Age

1970
The antiparkinsonian activity of monoamine oxidase inhibitors and other agents in rats and mice.
    Archives internationales de pharmacodynamie et de therapie, 1968, Volume: 176, Issue:1

    Topics: Animals; Dextroamphetamine; Diphenhydramine; Imipramine; Iproniazid; Isocarboxazid; Mice; Monoamine

1968